Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Other Medical Devices
isopharm.co.uk

See what CB Insights has to offer

Founded Year

1999

Stage

Acquired | Acquired

About Isopharm

Isopharm provides knowledge, training, and products to those conducting decontamination of medical devices and infection control within a healthcare environment.On June 22, 2020, Isopharm was acquired by Code. The terms of the transaction were not disclosed.

Isopharm Headquarter Location

Unit 18 Jessops Riverside 800 Brightside Lane

Sheffield, England, S9 2RX,

United Kingdom

+44 (0) 114 354 0137

Latest Isopharm News

Healthtech acquisition creates market leader

Jun 23, 2020

Healthtech company Isopharm has been acquired by compliance platform, CODE. The Sheffield-based business is the leading provider of online CPD for the dental market using innovative solutions to meet the mandatory requirements for continuous development. The business also provides software and services for validation and testing to a broad range of healthcare providers. The deal is the result of four years of dialogue between Isopharm and CODE’s investors, London-based August Equity. It also marks the start of the business’ expansion into adjacent healthcare market verticals, creating the market leader in dental compliance. Andrew Kemp, founder of Isopharm said: “CODE is the perfect platform for the next stage of innovative solutions we had planned; we are delighted to be joining forces”. James Bakewell, director (August Equity and CODE) added: “We are thrilled to have been able to unite CODE and Isopharm to create a highly unique and strategic compliance-focussed business in a market that offers significant opportunity. The combination of software-led compliance solutions and online training to the healthcare market is exciting – a market that’s undergoing a technology-focussed structural shift. We are extremely excited about combining the businesses and working closely with Andrew and the team at Isopharm”. Isopharm was advised on the deal Paul Johnson, partner and principal associate Vicky Protano of Mills & Reeve CODE was advised by Paul Mann, partner and associates Guy Ruddy and Nathan Bentley of Squire Paton Boggs, alongside 8Advisory (Financial), PwC (Commercial), and CMS (Legal). Previous Article

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.